Insulin-Like Growth Factor 1 Receptor Drives Hepatocellular Carcinoma Growth and Invasion by Activating Stat3-Midkine-Stat3 Loop
Authors:
- 9 February 2021
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 67 (2) , 569-584
Abstract
Background Activation of the insulin-like growth factor 1 receptor (IGF-1R)-mediated Janus kinase (JAK)1/2-Stat3 pathway contributes to hepatocarcinogenesis. Specifically, a previous study showed that IGF-1R inhibition downregulated Midkine expression in hepatocellular carcinoma (HCC). Aims The present study investigated the role of IGF-1R-JAK1/2-Stat3 and Midkine signaling in HCC, in addition to the molecular link between the IGF-1R-Stat3 pathway and Midkine. Methods The expression levels of IGF-1R, Stat3, and Midkine were measured using reverse transcription-quantitative PCR, following which the association of IGF-1R with Stat3 and Midkine expression was evaluated in HCC. The molecular link between the IGF-1R-Stat3 pathway and Midkine was then investigated in vitro before the effect of IGF-1R-Stat3 and Midkine signaling on HCC growth and invasion was studied in vitro and in vivo. Results IGF-1R, Stat3, and Midkine mRNA overexpressions were all found in HCC, where the levels of Stat3 and Midkine mRNA correlated positively with those of IGF-1R. In addition, Midkine mRNA level also correlated positively with Stat3 mRNA expression in HCC tissues. IGF-1R promoted Stat3 activation, which in turn led to the upregulation of Midkine expression in Huh7 cells. Similarly, Midkine also promoted Stat3 activation through potentiating JAK1/2 phosphorylation. Persistent activation of this Stat3-Midkine-Stat3 positive feedback signal loop promoted HCC growth and invasion, the inhibition of which resulted in significant antitumor activities both in vitro and in vivo. Conclusions Constitutive activation of the IGF-1R-mediated Stat3-Midkine-Stat3 positive feedback loop is present in HCC, the inhibition of which can serve as a potential therapeutic intervention strategy for HCC.Keywords
Funding Information
- Grants from Shenzhen Science and Technology Project of China (JCYJ20160428100513152)
- Department of Science and Technology of Hunan Province (2017SK4010)
- 7th batch Key Laboratory Project of colleges and universities of Hunan Province (2019-301)
- Medical Science and Technology Foundation of Guangdong Province (A2019256)
- Natural Science Foundation of Guangdong Province (2018A0303130302)
- Medical Science and Technology Foundation of Guangdong Province (A2018011)
This publication has 52 references indexed in Scilit:
- Tumor location determines midkine level and its association with the disease progression in colorectal cancer patients: a pilot studyInternational Journal of Colorectal Disease, 2012
- Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experienceThe Korean Journal of Hepatology, 2012
- IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockageJournal of Hepatology, 2010
- Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 ActivationCancer Cell, 2010
- A candidate targeting molecule of insulin-like growth factor-I receptor for gastrointestinal cancersWorld Journal of Gastroenterology, 2010
- Will targeting insulin growth factor help us or hurt us?: An oncologist's perspectiveAgeing Research Reviews, 2009
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Receptor tyrosine kinases: mechanisms of activation and signalingCurrent Opinion in Cell Biology, 2007
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- SOCS Proteins: Negative Regulators of Cytokine SignalingStem Cells, 2001